Project Number 5R21AG055047-02 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for New Drug Discovery Paradigms for Synucleinopathies Research Categorization Primary Disease / Condition Alzheimer's Disease Lewy Body Dementias CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) i. Proteostasis/Proteinopathies Researcher and Organization Principal Investigator REICHMAN, MELVIN Principal Investigator First Name MELVIN Principal Investigator Last Name REICHMAN Awardee Organization LANKENAU INSTITUTE FOR MEDICAL RESEARCH Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-042: DRUG DISCOVERY FOR NERVOUS SYSTEM DISORDERS (R21) FY Overall Cost $201,111 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO